assessment of consensus-based pharmacological therapies in irritable bowel syndrome

Context]the irritable bowel syndrome (ibs) is a symptombased gastrointestinal (gi) disease with the presence of symptoms such as abdominal pain and abnormal intestinal activities. it is a frequent gi problem encountered by physicians. the purpose of this paper was to review and assess some of the current and emerging pharmacological therapies for this syndrome.[evidence acquisition]in the present study, data on the ibs were principally collected via google scholar and pubmed, followed by articles in journals and libraries.[results]the pathophysiology of the ibs has yet to be fully elucidated. global medical attempts, including pharmacological therapy and herbal remedies, aim at curing and/or subsiding pain, flatulence, diarrhea, and constipation.[conclusions]there is a need for new drugs in the setting of pharmacological therapy for the ibs. a new medical approach should include both novel and traditional drugs in order to reach to a desirable outcome for patients and improve their quality of life.